Paragraph 4 F1
The details of the prescribed product, including where applicable the—
(a)
common name as defined by Article 1 of Directive 2001/83/EC;
(b)
brand name if—
(i)
the prescribed product is a biological medicinal product as referred to in point 3.2.1.1.(b) of Annex 1 (Part 1) to Directive 2001/83/EC; or
(ii)
the prescribing professional deems it medically necessary for that product to be dispensed and, in that case, the prescribing professional’s reasons justifying the use of the brand name;
(c)
pharmaceutical formulation (such as tablet, solution etc.);
(d)
quantity;
(e)
strength as defined in Article 1 of Directive 2001/83/EC; and
(f)
dosage regimen.